National Institute on Drug Abuse; Notice of Closed Meetings, 23261-23262 [E8-9283]

Download as PDF Federal Register / Vol. 73, No. 83 / Tuesday, April 29, 2008 / Notices 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS) Dated: April 21, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9156 Filed 4–28–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings sroberts on PROD1PC70 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; PREDICT. Date: May 16, 2008 Time: 11:30 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Neuroscience Center, 6001 Executive Boulevard,Rockville, MD 20852(Telephone Conference Call). Contact Person: David I. Sommers, PhD, Scientific Review Administrator, Division of Extramural Activities,National Institute of Mental Health,National Institutes of Health,6001 Executive Blvd., Room 6154, MSC 9609,Bethesda, MD 20892–9606,301– 443–7861, dsommers@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Prefrontal cortex RFA review panel. Date: May 20, 2008. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Neuroscience Center, 6001 Executive Boulevard,Rockville, MD 20852(Telephone Conference Call). Contact Person: Megan Libbey, PhD, Scientific Review Administrator, Division of Extramural Activities,National Institute of Mental Health, NIH,Neuroscience Center,6001 Executive Blvd., Room 6148, MSC 9609,Rockville, MD 20852,301–402– 6807, libbeymmail.nih.gov. VerDate Aug<31>2005 21:01 Apr 28, 2008 Jkt 214001 Name of Committee: National Institute of Mental Health Special Emphasis Panel; Eating Disorder Interventions. Date: May 28, 2008. Time: 3:30 p.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard,Rockville, MD 20852(Telephone Conference Call). Contact Person: David I. Sommers, PhD, Scientific Review Administrator, Division of Extramural Activities,National Institute of Mental Health,National Institutes of Health,6001 Executive Blvd., Room 6154, MSC 9609,Bethesda, MD 20892–9606,301– 443–7861, dsommers@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Insomnia Treatment. Date: June 27, 2008. Time: 10:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard,Rockville, MD 20852(Telephone Conference Call). Contact Person: David I. Sommers, PhD, Scientific Review Administrator, Division of Extramural Activities,National Institute of Mental Health,National Institutes of Health,6001 Executive Blvd., Room 6154, MSC 9609,Bethesda, MD 20892–9606,301– 443–7861, dsommers@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: April 21, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9162 Filed 4–28–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 23261 property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review of R21s. Date: June 4, 2008. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Bethesda, MD 20892(Telephone Conference Call). Contact Person: Jonathan Horsford, PhD, Scientific Review Officer, NIDCR,45 Center Drive, 4AN–24E,Bethesda, MD 20892,301– 594–4859, horsforj@mail.nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel. Date: June 16, 2008. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Bethesda, MD 20892(Telephone Conference Call). Contact Person: Jonathan Horsford, PhD, Scientific Review Officer NIDCR, 45 Center Drive, 4AN–24E,Bethesda, MD 20892,301– 594–4859, horsforj@mail.nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel. Date: July 30, 2008. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Bethesda, MD 20892(Telephone Conference Call). Contact Person: Jonathan Horsford, PhD, Scientific Review Officer NIDCR, 45 Center Drive, 4AN–24E,Bethesda, MD 20892,301– 594–4859, horsforj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: April 21, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9164 Filed 4–28–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. E:\FR\FM\29APN1.SGM 29APN1 23262 Federal Register / Vol. 73, No. 83 / Tuesday, April 29, 2008 / Notices sroberts on PROD1PC70 with NOTICES The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Drug Interactions. Date: May 15, 2008. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852(Telephone Conference Call). Contact Person: Gerald L. McLaughlin, PhD, Scientific Review Administrator,Office of Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 220, MSC 8401,6101 Executive Blvd. Bethesda, MD 20892–8401,301–402–6626, gm145a@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA L Conflicts. Date: June 2, 2008. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue,Bethesda, MD 20814. Contact Person: Meenaxi Hiremath, PhD, Health Scientist Administrator, Office of Extramural Affairs,National Institute on Drug Abuse,National Institutes of Health, DHHS,6101 Executive Blvd., Suite 220, MSC 8401,Bethesda, MD 20892,301–402–7964, mh392g@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA– E Conflicts. Date: June 4, 2008. Time: 2:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: Jurys Washington Hotel, 1500 New Hampshire Avenue, Washington, DC 20036. Contact Person: Jose F. Ruiz, PhD, Scientific Review Administrator, Office of Extramural Affairs,National Institute on Drug Abuse, NIH,6101 Executive Blvd., Rm. 213, MSC 8401,Bethesda, MD 20892,301–451– 3086, ruizjf@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDAF Conflicts. Date: June 4, 2008. Time: 4:30 p.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Jury Washington Hotel, 1500 New Hampshire Avenue, Washington, DC 20036. Contact Person: Jose F. Ruiz, PhD, Scientific Review Administrator, Office of Extramural Affairs,National Institute on Drug VerDate Aug<31>2005 21:01 Apr 28, 2008 Jkt 214001 Abuse, NIH,6101 Executive Blvd., Rm. 213, MSC 8401,Bethesda, MD 20892,301–451– 3086, ruizjf@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Center Review Committee. Date: July 21–23, 2008. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington DC 20037. Contact Person: Rita Liu, PhD, Associate Director, Office of Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 212, MSC 8401,6101 Executive Boulevard,Bethesda, MD 20892– 8401,301.435.1388, rliu@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Program Projects Review Committee. Date: July 22, 2008. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington, DC 20037. Contact Person: Rita Liu, PhD, Associate Director, Office of Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 212, MSC 8401,6101 Executive Boulevard,Bethesda, MD 20892– 8401,301.435.1388, rliu@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Center Review. Date: July 23–24, 2008. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington, DC 20037. Contact Person: Rita Liu, PHD, Associate Director, Office of Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 212, MSC 8401,6101 Executive Boulevard,Bethesda, MD 20892– 8401,301.435.1388, rliu@nida.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: April 22, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9283 Filed 4–28–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Primary ImmunoDeficiencies. Date: May 19, 2008. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive 3121, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Paul A. Amstad, PhD, Scientific Review Officer, Scientific Review Program,Division of Extramural Activities,DHHS/National Institutes of Health/NIAID,6700B Rockledge Drive, MSC 7616,Bethesda, MD 20892–7616,301–402– 7098, pamstad@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Helper T Cell Immunity. Date: May 28, 2008. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817(Telephone Conference Call). Contact Person: Paul A. Amstad, PhD, Scientific Review Officer, Scientific Review Program,Division of Extramural Activities,DHHS/National Institutes of Health/NIAID,6700B Rockledge Drive, MSC 7616,Bethesda, MD 20892–7616,301–402– 7098, pamstad@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: April 22, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9285 Filed 4–28–08; 8:45 am] BILLING CODE 4140–01–M Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 E:\FR\FM\29APN1.SGM 29APN1

Agencies

[Federal Register Volume 73, Number 83 (Tuesday, April 29, 2008)]
[Notices]
[Pages 23261-23262]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-9283]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.

[[Page 23262]]

    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Drug Interactions.
    Date: May 15, 2008.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852(Telephone Conference Call).
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator,Office of Extramural Affairs,National Institute on 
Drug Abuse, NIH, DHHS,Room 220, MSC 8401,6101 Executive Blvd. 
Bethesda, MD 20892-8401,301-402-6626, gm145a@nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA L Conflicts.
    Date: June 2, 2008.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue,Bethesda, MD 20814.
    Contact Person: Meenaxi Hiremath, PhD, Health Scientist 
Administrator, Office of Extramural Affairs,National Institute on 
Drug Abuse,National Institutes of Health, DHHS,6101 Executive Blvd., 
Suite 220, MSC 8401,Bethesda, MD 20892,301-402-7964, mh392g@nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA-E Conflicts.
    Date: June 4, 2008.
    Time: 2:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Jurys Washington Hotel, 1500 New Hampshire Avenue, 
Washington, DC 20036.
    Contact Person: Jose F. Ruiz, PhD, Scientific Review 
Administrator, Office of Extramural Affairs,National Institute on 
Drug Abuse, NIH,6101 Executive Blvd., Rm. 213, MSC 8401,Bethesda, MD 
20892,301-451-3086, ruizjf@nida.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA-F Conflicts.
    Date: June 4, 2008.
    Time: 4:30 p.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Jury Washington Hotel, 1500 New Hampshire Avenue, 
Washington, DC 20036.
    Contact Person: Jose F. Ruiz, PhD, Scientific Review 
Administrator, Office of Extramural Affairs,National Institute on 
Drug Abuse, NIH,6101 Executive Blvd., Rm. 213, MSC 8401,Bethesda, MD 
20892,301-451-3086, ruizjf@nida.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special
    Emphasis Panel; Center Review Committee.
    Date: July 21-23, 2008.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street, NW., 
Washington DC 20037.
    Contact Person: Rita Liu, PhD, Associate Director, Office of 
Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 
212, MSC 8401,6101 Executive Boulevard,Bethesda, MD 20892-
8401,301.435.1388, rliu@nida.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Program Projects Review Committee.
    Date: July 22, 2008.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street, NW., 
Washington, DC 20037.
    Contact Person: Rita Liu, PhD, Associate Director, Office of 
Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 
212, MSC 8401,6101 Executive Boulevard,Bethesda, MD 20892-
8401,301.435.1388, rliu@nida.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Center Review.
    Date: July 23-24, 2008.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street, NW., 
Washington, DC 20037.
    Contact Person: Rita Liu, PHD, Associate Director, Office of 
Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 
212, MSC 8401,6101 Executive Boulevard,Bethesda, MD 20892-
8401,301.435.1388, rliu@nida.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: April 22, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-9283 Filed 4-28-08; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.